» Articles » PMID: 24880746

Physiological and Pathological Functions of NADPH Oxidases During Myocardial Ischemia-reperfusion

Overview
Date 2014 Jun 2
PMID 24880746
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress, the presence of reactive oxygen species (ROS) in excess of the antioxidant capacity in the heart induces myocardial damage, accumulation of which leads to ischemic heart disease and heart failure. NADPH oxidase (Nox) 2 and 4 are the major sources of O2- and H2O2 in the heart and play a crucial role in the regulation of growth and death in cardiomyocytes. Both Nox2 and Nox4 are upregulated in response to ischemia-reperfusion (I/R), thereby contributing to ROS production and consequent myocardial injury. Suppression of either one of them can reduce ROS and I/R injury in the heart. Importantly, however, a minimum level of ROS production by either Nox2 or Nox4 is essential for the activation of HIF-1α and inhibition of PPARα during I/R, such that combined suppression of both Nox2 and Nox4 exacerbates myocardial I/R injury. Thus, either excessive activation or suppression of Noxs below physiological levels can induce cardiac injury. Here we discuss both detrimental and salutary functions of Nox isoforms during myocardial I/R.

Citing Articles

In defence of ferroptosis.

Alves F, Lane D, Nguyen T, Bush A, Ayton S Signal Transduct Target Ther. 2025; 10(1):2.

PMID: 39746918 PMC: 11696223. DOI: 10.1038/s41392-024-02088-5.


Specific NOX4 Inhibition Preserves Mitochondrial Function and Dampens Kidney Dysfunction Following Ischemia-Reperfusion-Induced Kidney Injury.

Schiffer T, Carvalho L, Guimaraes D, Boeder A, Wikstrom P, Carlstrom M Antioxidants (Basel). 2024; 13(4).

PMID: 38671936 PMC: 11047485. DOI: 10.3390/antiox13040489.


Knockdown of ANGPTL2 promotes left ventricular systolic dysfunction by upregulation of NOX4 in mice.

Labbe P, Martel C, Shi Y, Montezano A, He Y, Gillis M Front Physiol. 2024; 15:1320065.

PMID: 38426206 PMC: 10902461. DOI: 10.3389/fphys.2024.1320065.


Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic Myocardium.

Harris D, Sabe S, Broadwin M, Xu C, Stone C, Kanuparthy M Bioengineering (Basel). 2024; 11(2).

PMID: 38391611 PMC: 10886197. DOI: 10.3390/bioengineering11020125.


Cardiac endothelial ischemia/reperfusion injury-derived protein damage-associated molecular patterns disrupt the integrity of the endothelial barrier.

Kumphune S, Seenak P, Paiyabhrom N, Songjang W, Pankhong P, Jumroon N Heliyon. 2024; 10(2):e24600.

PMID: 38312663 PMC: 10835233. DOI: 10.1016/j.heliyon.2024.e24600.


References
1.
Ago T, Kuroda J, Pain J, Fu C, Li H, Sadoshima J . Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res. 2010; 106(7):1253-64. PMC: 2855780. DOI: 10.1161/CIRCRESAHA.109.213116. View

2.
Tazzeo T, Worek F, Janssen L . The NADPH oxidase inhibitor diphenyleneiodonium is also a potent inhibitor of cholinesterases and the internal Ca(2+) pump. Br J Pharmacol. 2009; 158(3):790-6. PMC: 2765598. DOI: 10.1111/j.1476-5381.2009.00394.x. View

3.
Matsuno K, Iwata K, Matsumoto M, Katsuyama M, Cui W, Murata A . NOX1/NADPH oxidase is involved in endotoxin-induced cardiomyocyte apoptosis. Free Radic Biol Med. 2012; 53(9):1718-28. DOI: 10.1016/j.freeradbiomed.2012.08.590. View

4.
Jiang J, Chen X, Serizawa N, Szyndralewiez C, Page P, Schroder K . Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med. 2012; 53(2):289-96. PMC: 3392471. DOI: 10.1016/j.freeradbiomed.2012.05.007. View

5.
Lyle A, Deshpande N, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P . Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res. 2009; 105(3):249-59. PMC: 2744198. DOI: 10.1161/CIRCRESAHA.109.193722. View